On the public citation graph

Twenty Years of Global Surveillance of Antituberculosis-Drug Resistance

https://doi.org/10.1056/nejmsr1512438
0 signed · 171 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1016/0140-6736(91)92559-kopenalex-snapshot
Emergence of drug-resistant Mycobacterium tuberculosis in HIV-infected patients
inferredcites →https://doi.org/10.1016/j.drup.2014.10.001openalex-snapshot
On the spread and control of MDR-TB epidemics: An examination of trends in anti-tuberculosis drug resistance surveillance data
inferredcites →https://doi.org/10.1016/s0140-6736(06)69573-1openalex-snapshot
Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa
inferredcites →https://doi.org/10.1016/s0140-6736(06)69863-2openalex-snapshot
Epidemiology of antituberculosis drug resistance (the Global Project on Anti-tuberculosis Drug Resistance Surveillance): an updated analysis
inferredcites →https://doi.org/10.1016/s0140-6736(09)60331-7openalex-snapshot
Epidemiology of antituberculosis drug resistance 2002–07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance
inferredcites →https://doi.org/10.1016/s0140-6736(12)60734-xopenalex-snapshot
Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort study
inferredcites →https://doi.org/10.1016/s0140-6736(14)62002-xopenalex-snapshot
Efficiency and safety of the combination of moxifloxacin, pretomanid (PA-824), and pyrazinamide during the first 8 weeks of antituberculosis treatment: a phase 2b, open-label, partly randomised trial in patients with drug-susceptible or drug-resistant pulmonary tuberculosis
inferredcites →https://doi.org/10.1016/s1473-3099(13)70130-0openalex-snapshot
Universal access to care for multidrug-resistant tuberculosis: an analysis of surveillance data
inferredcites →https://doi.org/10.1016/s8756-3452(08)70748-5openalex-snapshot
Epidemiology of antituberculosis drug resistance (the Global Project on Anti-tuberculosis Drug Resistance Surveillance): an updated analysis
inferredcites →https://doi.org/10.1038/ng.2747openalex-snapshot
Genomic analysis identifies targets of convergent positive selection in drug-resistant Mycobacterium tuberculosis
inferredcites →https://doi.org/10.1038/nrmicro2048openalex-snapshot
Doomsday postponed? Preventing and reversing epidemics of drug-resistant tuberculosis
inferredcites →https://doi.org/10.1046/j.1365-3156.2002.00960.xopenalex-snapshot
Increasing transparency in partnerships for health – introducing the Green Light Committee
inferredcites →https://doi.org/10.1056/nejm199302253280801openalex-snapshot
The Emergence of Drug-Resistant Tuberculosis in New York City
inferredcites →https://doi.org/10.1056/nejm199806043382301openalex-snapshot
Global Surveillance for Antituberculosis-Drug Resistance, 1994–1997
inferredcites →https://doi.org/10.1056/nejm200104263441706openalex-snapshot
Global Trends in Resistance to Antituberculosis Drugs
inferredcites →https://doi.org/10.1097/00002030-199809000-00018openalex-snapshot
An outbreak of multidrug-resistant tuberculosis involving HIV-infected patients of two hospitals in Milan, Italy
inferredcites →https://doi.org/10.1126/science.1063814openalex-snapshot
Erasing the World's Slow Stain: Strategies to Beat Multidrug-Resistant Tuberculosis
inferredcites →https://doi.org/10.1136/bmj.2.4588.1009openalex-snapshot
Streptomycin Resistance in Pulmonary Tuberculosis
inferredcites →https://doi.org/10.1172/jci103910openalex-snapshot
COMBINED DRUG TREATMENT OF TUBERCULOSIS. I. PREVENTION OF EMERGENCE OF MUTANT POPULATIONS OF TUBERCLE BACILLI RESISTANT TO BOTH STREPTOMYCIN AND ISONIAZID IN VITRO
inferredcites →https://doi.org/10.1183/09031936.00111812openalex-snapshot
Assessing spatial heterogeneity of multidrug-resistant tuberculosis in a high-burden country
inferredcites →https://doi.org/10.1183/09031936.00157212openalex-snapshot
Rapid molecular TB diagnosis: evidence, policy making and global implementation of Xpert MTB/RIF
inferredcites →https://doi.org/10.1183/09031936.00175812openalex-snapshot
Multidrug-resistant tuberculosis in children: evidence from global surveillance
inferredcites →https://doi.org/10.1183/09031936.00205413openalex-snapshot
HIV and multidrug-resistant tuberculosis: overlapping epidemics
inferredcites →https://doi.org/10.1186/1471-2458-10-355openalex-snapshot
Estimating the magnitude and direction of bias in tuberculosis drug resistance surveys conducted only in the public sector: a simulation study
inferredcites →https://doi.org/10.1371/journal.pone.0082235openalex-snapshot
Association between HIV/AIDS and Multi-Drug Resistance Tuberculosis: A Systematic Review and Meta-Analysis
inferredcites →https://doi.org/10.2471/blt.11.092585openalex-snapshot
Surveillance of anti-tuberculosis drug resistance in the world: an updated analysis, 2007–2010

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4194562openalex-extracted
The Wastewater Resistome of Residential Aged Care Facilities Indicates a Role of Antimicrobial Stewardship in Reducing Resistance
inferred← citeshttps://doi.org/10.1002/9781119282686.ch1openalex-snapshot
The Burden of Communicable Diseases in Low‐ and Middle‐Income Countries
inferred← citeshttps://doi.org/10.1002/jso.25038openalex-snapshot
Efficacy of prophylactic probiotics in combination with antibiotics versus antibiotics alone for colorectal surgery: A meta‐analysis of randomized controlled trials
inferred← citeshttps://doi.org/10.1002/slct.201702116openalex-snapshot
One Pot Synthesis and Biological Evaluation of Some New Pyridine‐3,5‐dicarbonitrile Derivatives
inferred← citeshttps://doi.org/10.1007/978-3-030-29108-2_10openalex-snapshot
Drug-Resistant Tuberculosis and HIV
inferred← citeshttps://doi.org/10.1007/978-3-319-28100-1_46-1openalex-snapshot
Non-odontogenic Bacterial Infections
inferred← citeshttps://doi.org/10.1007/978-3-319-28100-1_46-2openalex-snapshot
Non-Odontogenic Bacterial Infections
inferred← citeshttps://doi.org/10.1007/978-3-319-72303-7_46openalex-snapshot
Non-odontogenic Bacterial Infections
inferred← citeshttps://doi.org/10.1007/978-3-319-78538-7_5openalex-snapshot
Drug Resistance in Tuberculosis
inferred← citeshttps://doi.org/10.1007/978-981-16-8957-4_11openalex-snapshot
Microbiome in Pulmonary Tuberculosis
inferred← citeshttps://doi.org/10.1007/s00706-019-02457-9openalex-snapshot
Design, synthesis, antitubercular and antiviral properties of new spirocyclic indole derivatives
inferred← citeshttps://doi.org/10.1007/s12039-020-01872-4openalex-snapshot
Synthesis of some novel piperidine fused 5-thioxo-1H-1,2,4-triazoles as potential antimicrobial and antitubercular agents
inferred← citeshttps://doi.org/10.1007/s15010-019-01314-5openalex-snapshot
Implementation of multidrug-resistant tuberculosis (MDR-TB) treatment in Gabon: lessons learnt from the field
inferred← citeshttps://doi.org/10.1007/s40336-017-0259-2openalex-snapshot
Value of FDG-PET/CT for treatment response in tuberculosis: a systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1007/s40506-019-0182-3openalex-snapshot
Treatment of Tuberculosis in Brazil—Past, Present, and Future Challenges
inferred← citeshttps://doi.org/10.1016/b978-0-12-804607-4.00019-8openalex-snapshot
Bacterial Diseases of the Nervous System
inferred← citeshttps://doi.org/10.1016/bs.aihch.2022.11.001openalex-snapshot
The application of the Fischer indole synthesis in medicinal chemistry
inferred← citeshttps://doi.org/10.1016/j.bioorg.2022.106250openalex-snapshot
Design, synthesis and biological evaluation of alkynyl-containing maleimide derivatives for the treatment of drug-resistant tuberculosis
inferred← citeshttps://doi.org/10.1016/j.bmcl.2017.07.008openalex-snapshot
Synthesis and biological evaluation of novel 1,2,3-triazole derivatives as anti-tubercular agents
inferred← citeshttps://doi.org/10.1016/j.bmcl.2018.12.009openalex-snapshot
Synthesis, biological evaluation and molecular docking study of 1,2,3-1H-triazoles having 4H-pyrano[2,3-d]pyrimidine as potential Mycobacterium tuberculosis protein tyrosine phosphatase B inhibitors
inferred← citeshttps://doi.org/10.1016/j.ccm.2019.07.005openalex-snapshot
Tuberculosis Supranational Reference Laboratories
inferred← citeshttps://doi.org/10.1016/j.ccm.2019.07.009openalex-snapshot
The Future of Vaccines for Tuberculosis
inferred← citeshttps://doi.org/10.1016/j.cmi.2018.02.022openalex-snapshot
Antimicrobial resistance in leprosy: results of the first prospective open survey conducted by a WHO surveillance network for the period 2009–15
inferred← citeshttps://doi.org/10.1016/j.copbio.2017.03.023openalex-snapshot
Novel and revisited approaches in antituberculosis drug discovery
inferred← citeshttps://doi.org/10.1016/j.heliyon.2024.e37583openalex-snapshot
Association of bacteriomes with drug susceptibility in lesions of pulmonary tuberculosis patients
inferred← citeshttps://doi.org/10.1016/j.ijantimicag.2025.107598openalex-snapshot
Enhanced targeted NGS assay for comprehensive diagnosis in tuberculosis and drug-resistant tuberculosis patients
inferred← citeshttps://doi.org/10.1016/j.ijtb.2020.11.006openalex-snapshot
Surveillance of tuberculosis
inferred← citeshttps://doi.org/10.1016/j.ijtb.2025.03.006openalex-snapshot
Targeting Mycobacterium tuberculosis F420-dependent dehydrogenases for new anti-tubercular drug discovery
inferred← citeshttps://doi.org/10.1016/j.medcle.2018.02.012openalex-snapshot
Epidemiological, clinical, microbiological and therapeutic differences in tuberculosis disease in patients with and without HIV infection
inferred← citeshttps://doi.org/10.1016/j.medcli.2017.10.021openalex-snapshot
Diferencias epidemiológicas, clínico-microbiológicas y terapéuticas de la enfermedad tuberculosa en pacientes con infección por VIH y sin ella
inferred← citeshttps://doi.org/10.1016/j.medmal.2018.04.400openalex-snapshot
Characteristics and outcome of multidrug-resistant tuberculosis in a low-incidence area
inferred← citeshttps://doi.org/10.1016/j.microb.2024.100038openalex-snapshot
Comparison of molecular and microbiological detection rates of Mycobacterium tuberculosis and prevalence of SARS-CoV-2 variants in Monterrey, Mexico
inferred← citeshttps://doi.org/10.1016/j.scitotenv.2021.148815openalex-snapshot
Antimicrobial resistance bacteria and genes detected in hospital sewage provide valuable information in predicting clinical antimicrobial resistance
inferred← citeshttps://doi.org/10.1016/j.scitotenv.2024.175850openalex-snapshot
Sewerage surveillance tracking characteristics of human antibiotic resistance genes in sewer system
inferred← citeshttps://doi.org/10.1016/j.sempedsurg.2026.151623openalex-snapshot
Infections in pediatric surgical practice in low- and middle-income countries: Resource-adapted clinical decision-making
inferred← citeshttps://doi.org/10.1016/j.tube.2018.08.004openalex-snapshot
The EU approved antimalarial pyronaridine shows antitubercular activity and synergy with rifampicin, targeting RNA polymerase
inferred← citeshttps://doi.org/10.1016/s1473-3099(16)30538-2openalex-snapshot
Resistance of Mycobacterium tuberculosis isolates to pyrazinamide and fluoroquinolones – Authors' reply
inferred← citeshttps://doi.org/10.1016/s1473-3099(17)30299-2openalex-snapshot
Population implications of the use of bedaquiline in people with extensively drug-resistant tuberculosis: are fears of resistance justified?
inferred← citeshttps://doi.org/10.1016/s1473-3099(18)30073-2openalex-snapshot
Genetic sequencing for surveillance of drug resistance in tuberculosis in highly endemic countries: a multi-country population-based surveillance study
inferred← citeshttps://doi.org/10.1016/s1473-3099(18)30110-5openalex-snapshot
Tuberculosis: progress and advances in development of new drugs, treatment regimens, and host-directed therapies
inferred← citeshttps://doi.org/10.1016/s1473-3099(18)30161-0openalex-snapshot
Population monitoring for drug-resistant tuberculosis: is genomics the answer?
inferred← citeshttps://doi.org/10.1016/s1473-3099(19)30568-7openalex-snapshot
Drug-resistant tuberculosis in eastern Europe and central Asia: a time-series analysis of routine surveillance data
inferred← citeshttps://doi.org/10.1016/s1473-3099(21)00808-2openalex-snapshot
25 years of surveillance of drug-resistant tuberculosis: achievements, challenges, and way forward
inferred← citeshttps://doi.org/10.1016/s1473-3099(26)00295-1openalex-snapshot
Global, regional, and national burden of tuberculosis and multidrug-resistant tuberculosis by HIV status, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
inferred← citeshttps://doi.org/10.1016/s2214-109x(22)00045-6openalex-snapshot
Multidrug-resistant tuberculosis in Sierra Leone
inferred← citeshttps://doi.org/10.1017/ash.2025.170openalex-snapshot
Guidance for infectious disease care in the face of human conflict: a case-based narrative review
inferred← citeshttps://doi.org/10.1021/acs.molpharmaceut.1c00791openalex-snapshot
Machine Learning Models for Mycobacterium tuberculosis In Vitro Activity: Prediction and Target Visualization
inferred← citeshttps://doi.org/10.1038/s41467-019-08853-3openalex-snapshot
Global monitoring of antimicrobial resistance based on metagenomics analyses of urban sewage
inferred← citeshttps://doi.org/10.1038/s41598-017-17705-3openalex-snapshot
Culture and Next-generation sequencing-based drug susceptibility testing unveil high levels of drug-resistant-TB in Djibouti: results from the first national survey
inferred← citeshttps://doi.org/10.1038/s41598-018-21614-4openalex-snapshot
A multitarget approach to drug discovery inhibiting Mycobacterium tuberculosis PyrG and PanK
inferred← citeshttps://doi.org/10.1055/s-0038-1651492openalex-snapshot
Global Epidemiology of Tuberculosis
inferred← citeshttps://doi.org/10.1056/nejmc1613123openalex-snapshot
More on Treatment Outcomes in Multidrug-Resistant Tuberculosis
inferred← citeshttps://doi.org/10.1080/07391102.2020.1844055openalex-snapshot
Probing the dual inhibitory mechanisms of novel thiophenecarboxamide derivatives againstMycobacterium tuberculosisPyrG and PanK: an insight from biomolecular modeling study
inferred← citeshttps://doi.org/10.1080/10426507.2023.2201503openalex-snapshot
Novel thiourea derivatives against Mycobacterium tuberculosis: synthesis, characterization and molecular docking studies
inferred← citeshttps://doi.org/10.1080/10643389.2024.2344453openalex-snapshot
Standardization in global environmental antibiotic resistance genes (ARGs) surveillance
inferred← citeshttps://doi.org/10.1080/1120009x.2020.1716477openalex-snapshot
The molecular patterns of resistance to anti-tuberculosis drugs: an analysis from Istanbul, Turkey
inferred← citeshttps://doi.org/10.1080/14787210.2018.1472577openalex-snapshot
Use of whole genome sequencing in surveillance of drug resistant tuberculosis
inferred← citeshttps://doi.org/10.1080/17568919.2026.2636824openalex-snapshot
Structural insights of mycobacterial ATP synthase and recent updates on molecular recognition of Mtb ATP synthase inhibitors: a review
inferred← citeshttps://doi.org/10.1080/2331205x.2020.1783129openalex-snapshot
Association of MDR-TB treatment outcomes and HIV status in Zimbabwe: A retrospective study
inferred← citeshttps://doi.org/10.1093/cid/ciz219openalex-snapshot
Building the Framework for Standardized Clinical Laboratory Reporting of Next-generation Sequencing Data for Resistance-associated Mutations in Mycobacterium tuberculosis Complex
inferred← citeshttps://doi.org/10.1093/jac/dkaa394openalex-snapshot
AMR-Intervene: a social–ecological framework to capture the diversity of actions to tackle antimicrobial resistance from a One Health perspective
inferred← citeshttps://doi.org/10.1093/milmed/usaa111openalex-snapshot
Multidrug-Resistant Organisms from Ophthalmic Cultures: Antibiotic Resistance and Visual Acuity
inferred← citeshttps://doi.org/10.1093/oso/9780198799498.003.0025openalex-snapshot
The Utility of Systems Thinking in the Context of Infectious Disease Surveillance in India
inferred← citeshttps://doi.org/10.1097/md.0000000000045893openalex-snapshot
Fulminant hepatitis during treatment for per-extensively drug-resistant tuberculosis: A case report and call for improved patient monitoring
inferred← citeshttps://doi.org/10.1097/ms9.0000000000001859openalex-snapshot
New option: targeting RNase J and RNase HI in the fight against multi-drug-resistant tuberculosis
inferred← citeshttps://doi.org/10.1101/2022.11.03.22281872openalex-snapshot
Rapid Acquisition and Transmission of Drug Resistance Amongst Beijing Lineage Mycobacterium tuberculosis in Vietnam
inferred← citeshttps://doi.org/10.1111/tmi.13205openalex-snapshot
Low prevalence of MDR‐TB in Lao PDR: results from the first national anti‐tuberculosis drug resistance survey
inferred← citeshttps://doi.org/10.1111/tmi.14126openalex-snapshot
Characteristics and risk factors of drug‐resistant tuberculosis in Sichuan, China: An observational study
inferred← citeshttps://doi.org/10.1128/aac.00240-19openalex-snapshot
First-Time-in-Human Study and Prediction of Early Bactericidal Activity for GSK3036656, a Potent Leucyl-tRNA Synthetase Inhibitor for Tuberculosis Treatment
inferred← citeshttps://doi.org/10.1128/aac.01317-18openalex-snapshot
No Evidence for Acquired Mutations Associated with Cytochrome bc 1 Inhibitor Resistance in 13,559 Clinical Mycobacterium tuberculosis Complex Isolates
inferred← citeshttps://doi.org/10.1128/aac.02259-17openalex-snapshot
Time to Multidrug-Resistant Tuberculosis Treatment Initiation in Association with Treatment Outcomes in Shanghai, China
inferred← citeshttps://doi.org/10.1128/cmr.00140-22openalex-snapshot
Integrating whole-genome sequencing into antimicrobial resistance surveillance: methodologies, challenges, and perspectives
inferred← citeshttps://doi.org/10.1128/spectrum.00731-23openalex-snapshot
The scope of antimicrobial resistance in residential aged care facilities determined through analysis of Escherichia coli and the total wastewater resistome
inferred← citeshttps://doi.org/10.1128/spectrum.01358-21openalex-snapshot
Application of Amplicon-Based Targeted NGS Technology for Diagnosis of Drug-Resistant Tuberculosis Using FFPE Specimens
inferred← citeshttps://doi.org/10.1155/criu/2998895openalex-snapshot
Tuberculous/BCG‐Related Chronic Orchiepididymitis With Fistulization: Expanded Case Report and Literature Review
inferred← citeshttps://doi.org/10.1164/rccm.201909-1874stopenalex-snapshot
Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline
inferred← citeshttps://doi.org/10.1177/2472555218773034openalex-snapshot
Using Fragment-Based Approaches to Discover New Antibiotics
inferred← citeshttps://doi.org/10.1183/13993003.00361-2021openalex-snapshot
New definitions of pre-extensively and extensively drug-resistant tuberculosis: update from the World Health Organization
inferred← citeshttps://doi.org/10.1183/13993003.02308-2016openalex-snapshot
World Health Organization treatment guidelines for drug-resistant tuberculosis, 2016 update
inferred← citeshttps://doi.org/10.1183/13993003.02571-2017openalex-snapshot
Low prevalence of fluoroquinolone resistance among patients with tuberculosis in the Philippines: results of a national survey
inferred← citeshttps://doi.org/10.1183/13993003.03300-2020openalex-snapshot
World Health Organization recommendations on the treatment of drug-resistant tuberculosis, 2020 update
inferred← citeshttps://doi.org/10.1183/2312508x.10020817openalex-snapshot
Evolution of the strategies for control and elimination of tuberculosis
inferred← citeshttps://doi.org/10.1186/s12879-019-3943-1openalex-snapshot
Prevalence of rifampicin resistant Mycobacterium tuberculosis among presumptive tuberculosis patients in selected governmental hospitals in Addis Ababa, Ethiopia
inferred← citeshttps://doi.org/10.1186/s12879-026-12629-8openalex-snapshot
Rates and risk factors of monoresistance against isoniazid and multidrug-resistant tuberculosis in Almaty, Kazakhstan
inferred← citeshttps://doi.org/10.1186/s13073-016-0385-xopenalex-snapshot
The variability and reproducibility of whole genome sequencing technology for detecting resistance to anti-tuberculous drugs
inferred← citeshttps://doi.org/10.12659/msm.934292openalex-snapshot
Editorial: Updates from the World Health Organization (WHO) on Global Treatment Recommendations for Drug-Susceptible and Multidrug-Resistant Tuberculosis
inferred← citeshttps://doi.org/10.1371/journal.pgph.0004979openalex-snapshot
Tuberculosis laboratory capacity building in the WHO African Region: The past, the present and the future: A Viewpoint
inferred← citeshttps://doi.org/10.1371/journal.pmed.1003008openalex-snapshot
Prevalence and genetic profiles of isoniazid resistance in tuberculosis patients: A multicountry analysis of cross-sectional data
inferred← citeshttps://doi.org/10.1371/journal.pone.0197913openalex-snapshot
Automated IS6110-based fingerprinting of Mycobacterium tuberculosis: Reaching unprecedented discriminatory power and versatility
inferred← citeshttps://doi.org/10.1371/journal.pone.0220946openalex-snapshot
Clinical predictors of drug-resistant tuberculosis in Mexico
inferred← citeshttps://doi.org/10.1371/journal.pone.0262929openalex-snapshot
Detection of Mycobacterium tuberculosis and rifampicin resistance by Xpert® MTB/RIF assay among presumptive tuberculosis cases at Jimma University Medical Center, Southwest Ethiopia
inferred← citeshttps://doi.org/10.1371/journal.pone.0352863openalex-snapshot
Machine learning-based analysis of drug resistance mutations in Mycobacterium tuberculosis
inferred← citeshttps://doi.org/10.1515/zkri-2019-0032openalex-snapshot
Structural studies on dihydropyrimidine derivatives as Mycobacterium tuberculosis coenzyme-A carboxylase inhibitors
inferred← citeshttps://doi.org/10.15253/2175-6783.20212270733openalex-snapshot
Prevalence of drug-resistant tuberculosis and associated factors
inferred← citeshttps://doi.org/10.1556/1886.2018.00001openalex-snapshot
Multidrug-resistant tuberculosis in côte d'ivoire from 1995 to 2016: Results of national surveys
inferred← citeshttps://doi.org/10.15761/crt.1000178openalex-snapshot
HDFx: A novel biologic immunomodulator may have the potential to prevent bacteria in space from becoming aggressively infectious and lethal
inferred← citeshttps://doi.org/10.17352/2455-5479.000065openalex-snapshot
Epidemiology of drug-resistant tuberculosis in Bahrain, five years review
inferred← citeshttps://doi.org/10.19070/2332-2748-170006eopenalex-snapshot
HDFx: A Novel Immunomodulator and Potential Fighter Against Cytokine Storms in Inflammatory and Septic Conditions in Dogs and Farm Animals
inferred← citeshttps://doi.org/10.21070/acopen.9.2024.9412openalex-snapshot
Alarming Rise of MDR Bacteria in Uremia Patients in Iraq
inferred← citeshttps://doi.org/10.21070/acopen.9.2024.9841openalex-snapshot
Escalating Antibiotic Resistance in Uremia Patients Demands Urgent Global Action
inferred← citeshttps://doi.org/10.21203/rs.3.rs-2937470/v1openalex-snapshot
Detection and Frequency of Mycobacterium tuberculosis and Rifampicin Resistance Among Patients Attending the National TB Control Program in Sana'a, Yemen Using Xpert- MTB/RIF Assay
inferred← citeshttps://doi.org/10.21203/rs.3.rs-93424/v1openalex-snapshot
Antimicrobial Resistance Genes and Bacteria Detected in Hospital Sewage May Provide Valuable Information in Clinical Antimicrobial Resistance
inferred← citeshttps://doi.org/10.2147/idr.s188538openalex-snapshot
Drug resistance profiles and trends in drug-resistant tuberculosis at a major hospital in Guizhou Province of China
inferred← citeshttps://doi.org/10.2147/idr.s221408openalex-snapshot
The Anti-Mycobacterial Activity Of Ag, ZnO, And Ag- ZnO Nanoparticles Against MDR- And XDR-Mycobacterium tuberculosis
inferred← citeshttps://doi.org/10.2147/idr.s289965openalex-snapshot
Knowledge and Practice Toward Prevention of SARS-CoV-2 Among Healthcare Workers at Delghi Primary Hospital During a Massive Test Campaign in Northwest Gondar, Ethiopia: Institution-Based Descriptive Cross-Sectional Survey
inferred← citeshttps://doi.org/10.2147/idr.s300585openalex-snapshot
Magnitude of Mycobacterium tuberculosis Infection and Its Resistance to Rifampicin Using Xpert-MTB/RIF Assay Among Presumptive Tuberculosis Patients at Motta General Hospital, Northwest Ethiopia
inferred← citeshttps://doi.org/10.23750/abm.v88i1-s.6156openalex-snapshot
Risk factors for latent tuberculosis infection (LTBI) in health profession's students of the University of Parma.
inferred← citeshttps://doi.org/10.23888/pavlovj2019272137-149openalex-snapshot
The main risk factors and their impact on the hiv/tuberculosis epidemic
inferred← citeshttps://doi.org/10.26719/2017.23.6.393openalex-snapshot
What would it take to eliminate tuberculosis in the Eastern Mediterranean Region?
inferred← citeshttps://doi.org/10.3126/saarctb.v17i1.25019openalex-snapshot
An Observational Study of Follow Up of MDR Tuberculosis Patients after Successful Completion of Category 4 Treatment under RNTCP (PMDT) in Allahabad District
inferred← citeshttps://doi.org/10.3201/eid2503.180574openalex-snapshot
Exportation of MDR TB to Europe from Setting with Actively Transmitted Persistent Strains in Peru
inferred← citeshttps://doi.org/10.33073/pjm-2020-005openalex-snapshot
Prevalence of Multi-Drug Resistant Mycobacterium Tuberculosis in Khyber Pakhtunkhwa – A High Tuberculosis Endemic Area of Pakistan
inferred← citeshttps://doi.org/10.33582/2640-1193/1018openalex-snapshot
False Positive Rifampicin Resistance among HIV Patients attending Bahati Comprehensive Care Centre, Nairobi, Kenya
inferred← citeshttps://doi.org/10.3389/fmed.2018.00127openalex-snapshot
A Rapid Growth-Independent Antibiotic Resistance Detection Test by SYBR Green/Propidium Iodide Viability Assay
inferred← citeshttps://doi.org/10.3389/fmicb.2026.1828991openalex-snapshot
Whole-genome sequencing reveals lineage-associated drug resistance and enables machine learning–based prediction in Mycobacterium tuberculosis clinical isolates
inferred← citeshttps://doi.org/10.3389/fpubh.2022.1047659openalex-snapshot
Drug resistance patterns and dynamics of tuberculosis in Zhejiang Province, China: Results from five periodic longitudinal surveys
inferred← citeshttps://doi.org/10.3390/antibiotics10050520openalex-snapshot
Potential Application of Combined Therapy with Lectins as a Therapeutic Strategy for the Treatment of Bacterial Infections
inferred← citeshttps://doi.org/10.3390/ijerph18094393openalex-snapshot
Towards Solving Health Inequities: A Method to Identify Ideological Operation in Global Health Programs
inferred← citeshttps://doi.org/10.3390/microorganisms11051280openalex-snapshot
Burden of Pulmonary Rifampicin-Resistant Tuberculosis in Kajiado, Kenya: An Observational Study
inferred← citeshttps://doi.org/10.3390/molecules22010029openalex-snapshot
Antibiotic Resistant Superbugs: Assessment of the Interrelationship of Occurrence in Clinical Settings and Environmental Niches
inferred← citeshttps://doi.org/10.3390/molecules26144280openalex-snapshot
Oxazolidinone Antibiotics: Chemical, Biological and Analytical Aspects
inferred← citeshttps://doi.org/10.3390/ph16091326openalex-snapshot
Evaluation of Anti-Inflammatory and Anti-Tubercular Activity of 4-Methyl-7-Substituted Coumarin Hybrids and Their Structure Activity Relationships
inferred← citeshttps://doi.org/10.3390/ph17050548openalex-snapshot
NMI-SO2Cl2-Mediated Amide Bond Formation: Facile Synthesis of Some Dihydrotriazolopyrimidine Amide Derivatives as Potential Anti-Inflammatory and Anti-Tubercular Agents
inferred← citeshttps://doi.org/10.3390/pharmaceutics15020540openalex-snapshot
Mechanisms of a Mycobacterium tuberculosis Active Peptide
inferred← citeshttps://doi.org/10.3396/ijic.v17.20840openalex-snapshot
Antimicrobial drug resistance and infection prevention/control: lessons from tuberculosis
inferred← citeshttps://doi.org/10.3410/f.735262914.793563582openalex-snapshot
Faculty Opinions recommendation of Global monitoring of antimicrobial resistance based on metagenomics analyses of urban sewage.
inferred← citeshttps://doi.org/10.35663/amp.2021.382.1892openalex-snapshot
Mutaciones genéticas que confieren resistencia a Isoniacida en pacientes con tuberculosis en Lima Centro, Perú 2017-2018
inferred← citeshttps://doi.org/10.36348/sjm.2023.v08i12.007openalex-snapshot
Impact of Education on Non-Compliance and MDR TB Risk: Specialized Hospital Study
inferred← citeshttps://doi.org/10.4103/ajprhc.ajprhc_177_24openalex-snapshot
Synthesis of Novel Mannich Bases of Indole and N-phenylaniline with its Molecular Docking, In silico Absorption, Distribution, Metabolism, and Excretion Profiling, In vitro Anti Tubercular Activity and Cytotoxicity Studies
inferred← citeshttps://doi.org/10.4236/jtr.2019.71004openalex-snapshot
Multidrug-Resistant Tuberculosis in the Democratic Republic of Congo: Analysis of Continuous Surveillance Data from 2007 to 2016
inferred← citeshttps://doi.org/10.4236/pp.2023.141002openalex-snapshot
Oxazolidinones Antibiotics, Chemistry, Applications and Role in COVID-19 Treatment
inferred← citeshttps://doi.org/10.4269/ajtmh.16-0662openalex-snapshot
Resistance to First-Line Antituberculosis Drugs in Washington State by Region of Birth and Implications for Latent Tuberculosis Treatment Among Foreign-Born Individuals
inferred← citeshttps://doi.org/10.4274/imj.galenos.2022.64188openalex-snapshot
The Diagnostic Efficiency of the Use of Non-Standard Surgical Instruments in Mediastinoscopy
inferred← citeshttps://doi.org/10.53350/pjmhs2023175617openalex-snapshot
Frequency of Fluoroquinolone and Aminoglycoside Resistance Online Probe Assay in Multidrug-Resistant Tuberculosis Patients
inferred← citeshttps://doi.org/10.53846/goediss-8102openalex-snapshot
Assessment of antibiotic resistance in soil and its link to different land use types and intensities
inferred← citeshttps://doi.org/10.54112/bcsrj.v2022i1.164openalex-snapshot
USE OF GENE XPERT MTB/RIF ASSAY FOR DETECTING MYCOBACTERIUM TUBERCULOSIS AND RIFAMPICIN RESISTANCE
inferred← citeshttps://doi.org/10.5588/ijtld.18.0217openalex-snapshot
What will it take to eliminate drug-resistant tuberculosis?
inferred← citeshttps://doi.org/10.70675/0b85e2dfz956dz4573z8754z857a06866fd1openalex-snapshot
Développement de méthodes pour le diagnostic, le contrôle, la surveillance de la tuberculose à bacilles ultra-résistants et des souches épidémiques Beijing
inferred← citeshttps://doi.org/10.70675/b1318398z3b3ez47caza99cz49045a043924openalex-snapshot
Implication des enzymes lipolytiques dans la virulence et la survie mycobactérienne
inferred← citeshttps://doi.org/10.7287/peerj.6696v0.1/reviews/1openalex-snapshot
Peer Review #1 of "Rapid screening mutations of first-line-drug-resistant genes in Mycobacterium tuberculosis strains by allele-specific real-time quantitative PCR (v0.1)"
inferred← citeshttps://doi.org/10.7287/peerj.6696v0.1/reviews/2openalex-snapshot
Peer Review #2 of "Rapid screening mutations of first-line-drug-resistant genes in Mycobacterium tuberculosis strains by allele-specific real-time quantitative PCR (v0.1)"
inferred← citeshttps://doi.org/10.7287/peerj.6696v0.2/reviews/1openalex-snapshot
Peer Review #1 of "Rapid screening mutations of first-line-drug-resistant genes in Mycobacterium tuberculosis strains by allele-specific real-time quantitative PCR (v0.2)"
inferred← citeshttps://doi.org/10.7287/peerj.6696v0.2/reviews/2openalex-snapshot
Peer Review #2 of "Rapid screening mutations of first-line-drug-resistant genes in Mycobacterium tuberculosis strains by allele-specific real-time quantitative PCR (v0.2)"
inferred← citeshttps://doi.org/10.7324/japs.2020.10102openalex-snapshot
In silico targeting methylerythritol phosphate pathway IspD enzyme of Mycobacterium tuberculosis for novel anti-mycobacterial drug discovery
inferred← citeshttps://doi.org/10.7717/peerj.6696openalex-snapshot
Rapid screening mutations of first-line-drug-resistant genes in Mycobacterium tuberculosis strains by allele-specific real-time quantitative PCR
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.